SCHEMBL6089178

SCHEMBL6089178

CCC(O)(CC)c1ccc2sc(Cl)nc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.42
CASR P41180 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.39
DYRK1A Q13627 1/20 0.38
PPARA Q07869 5/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HSD17B10 Q99714 1/20 0.36
IDO1 P14902 1/20 0.36
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
TRPV1 Q8NER1 2/20 0.34
LCK P06239 1/20 0.34
TXK P42681 1/20 0.34
SYK P43405 1/20 0.34
ITK Q08881 1/20 0.34
AGPAT2 O15120 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6092062 0.88 KMT2A (0.52) KMT2ACASRSMN1; SMN2DYRK1APPARA
SCHEMBL6088891 0.83 HSD17B10 (0.54) KMT2ASMN1; SMN2NPSR1DYRK1AHSD17B10
SCHEMBL6090372 0.82 NOS3 (0.48) SMN1; SMN2DYRK1AHSD17B10
SCHEMBL777758 0.76 DYRK1A (0.52) KMT2ASMN1; SMN2NPSR1LOXL2DYRK1A
SCHEMBL8328404 0.75 KMT2A (0.40) KMT2ACASRSMN1; SMN2NPSR1LOXL2
SCHEMBL6089365 0.75 DYRK1A (0.70) SMN1; SMN2DYRK1A
SCHEMBL6090347 0.72 ALDH1A1 (0.39) KMT2ASMN1; SMN2NPSR1HSD17B10LCK
SCHEMBL780242 0.70 SMN1; SMN2 (0.61) KMT2ASMN1; SMN2NPSR1LOXL2PPARA
SCHEMBL6089162 0.70 SCN4A (0.60) KMT2ASMN1; SMN2HSD17B10
SCHEMBL30189802 0.70 SMN1; SMN2 (0.51) KMT2ASMN1; SMN2NPSR1LOXL2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 US disclosed
EP-1597254-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS Eli Lilly and Company (US) 2005-11-23 EP disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R KMT2A 3358/4885CASR 833/4885SMN1; SMN2 4558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.